entertainment -WSS

entertainment

author：entertainment 2025-09-07 17:29:18 - browse：5

A vial of Tofersen injection on the left of its box — The ALS drug tofersen is marketed as Qalsody in the U.S. Biogen

LONDON — Neurologists and patient advocates are up in arms over a policy decision by a U.K. health agency that they say will imperil access to an ALS treatment that’s available in the U.S. and on its way to approval in the European Union.

The medicine in question, Biogen’s tofersen, is designed to treat a rare genetic form of the neurodegenerative disease, accounting for some 2% of all ALS cases. And the issue is how the U.K.’s cost-effectiveness agency has said it would assess the costs and benefits of the therapy.

The agency, the National Institute for Health and Care Excellence, or NICE, has a special pathway for drugs for very rare diseases, which advocates and doctors argue is the route through which tofersen should be reviewed. But NICE has indicated it would review the drug through its standard process, saying it’s because ALS as a whole does not count as a “very rare” disease. That sets a higher bar to clear.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Welsh Carson private equity firm escapes from FTC antitrust case

Wikipedia

hotspot

WSS

Fed up with FDA, ALS advocates consider a take

The creative science of coining drug names

AI for drug discovery: Experts on separating hype from reality

Medicare to pay more for cardiac rehab in hospital outpatient clinics

HHS's proposed rule does nothing to address the climate crisis

Novel spinal cord stimulator treats paralysis without surgery

leisure time

entertainment

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Crowdfunding for medical bills sidesteps core problem, author says

Virginia high school admissions case could be legal follow

Has Bernie Sanders reached the limit of his pharma bullying effort?

Walensky prepares to leave CDC — and Congress — behind

Why the quest to eradicate polio has stumbled

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Black vets could get higher VA benefits if race not used in lung test

Peter Hotez and the public health issue of online harassment

Assistant physicians can help address the primary care shortage

Wikipedia

David Liu startup to focus on CRISPR delivery

Covid’s new normal has set in amid another rise in cases

FDA panel to weigh safety of artificial wombs for preterm births

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Eli Lilly CEO gives to Mike Pence presidential super PAC

'A game

focus

Wikipedia

hotspot

Wikipedia